Published in Steroids on February 22, 2001
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol (2008) 1.72
1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol (2010) 1.02
Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine. PLoS One (2012) 0.94
The Effect of Short Term Vitamin D Supplementation on the Inflammatory and Oxidative Mediators of Arterial Stiffness. Health (Irvine Calif) (2014) 0.84
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1. Sci Rep (2016) 0.79
Calcitriol derivatives with two different side-chains at C-20. Part 4: further chain modifications that alter VDR-dependent monocytic differentiation potency in human leukemia cells. Bioorg Med Chem (2007) 0.79
Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis. Int J Endocrinol (2010) 0.79
Single thyroid hormone receptor monomers are competent for co-activator-mediated transactivation. Biochem J (2001) 0.76
VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J (2000) 1.52
Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Expr (1998) 1.28
All natural DR3-type vitamin D response elements show a similar functionality in vitro. Biochem J (2000) 1.14
Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues. Cell Death Differ (1998) 0.97
High activity, soluble, bacterially expressed human vitamin D receptor and its ligand binding domain. J Cell Biochem (1996) 0.87
Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. Mol Pharmacol (2000) 0.86
Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab (1996) 0.86
Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains. J Cell Biochem Suppl (2001) 0.83
Identification of an osteocalcin gene promoter sequence that binds AP1. J Cell Biochem (1996) 0.82
[Fatal Salmonella enteritidis meningoencephalitis]. Dtsch Med Wochenschr (1993) 0.82
Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. J Bone Miner Res (2001) 0.81
Electroweak quantum chemistry of alanine: parity violation in gas and condensed phases. Chemphyschem (2000) 0.79
Panmixia in Zoarces viviparus: implications for environmental monitoring studies. J Fish Biol (2012) 0.78
Assessing noise sources at synchrotron infrared ports. J Synchrotron Radiat (2011) 0.75
[Therapy of interstitial and radiogenic cystitis with D-glucosamine]. Helv Chir Acta (1989) 0.75
High resolution Fourier transform spectroscopy of CH2D2 in the region 2350-2650 cm(-1): the bands nu5 + nu7, 2nu9, nu3 + nu4, nu3 + nu7 and nu5 + nu9. Phys Chem Chem Phys (2005) 0.75
High resolution spectroscopy and the first global analysis of the Tetradecad region of methane 12CH4. Phys Chem Chem Phys (2013) 0.75
High-resolution near infrared spectroscopy and vibrational dynamics of dideuteromethane (CH2D2). J Phys Chem A (2009) 0.75
[Suprapubic urinary diversion]. Krankenpfl J (1987) 0.75
Point mutations of the human parathyroid calcium receptor gene are not responsible for non-suppressible renal hyperparathyroidism. Kidney Int (1998) 0.75